BPA’s transgenerational disturbance to transcription of ovarian steroidogenic genes in rare minnow Gobiocypris rarus via DNA

November 7, 2020
 |  No Comments
geno-type

Evaluation of key genes and pathways in breast ductal carcinoma in situ

Breast most cancers (BC) stays the most common most cancers in females. As a result of this reality, the present analysis aimed to ascertain key genes involved inside the carcinogenesis of BC and to find their prognostic values by integrating bioinformatics devices. The gene expression profiles of 46 ductal carcinoma in situ (DCIS) and three common breast tissues from the GSE59248 dataset have been downloaded. Differentially expressed genes (DEGs) have been subsequently acknowledged using the online system GEO2R and a helpful enrichment analysis was carried out. In addition to, a protein-protein interaction (PPI) neighborhood was constructed and the best eight hub genes have been acknowledged.

 

The prognostic values of the hub genes have been extra investigated. A whole of 316 DEGs, along with 32 upregulated and 284 downregulated genes, have been acknowledged. Furthermore, eight hub genes, along with lipase E hormone delicate variety, patatin like phospholipase space containing 2, adiponectin C1Q and collagen space containing (ADIPOQ), peroxisome proliferator activated receptor γ (PPARG), fatty acid binding protein 4 (FABP4), diacylglycerol O-acyltransferase 2, lipoprotein lipase (LPL) and leptin (LEP), have been acknowledged from the PPI neighborhood.

 

The downregulated expression of ADIPOQ, PPARG, FABP4, LPL and LEP was significantly associated to poor whole survival in victims with DCIS. As a result of this reality, these genes might operate potential biomarkers for prognosis prediction. However, extra investigation is required to validate the outcomes obtained inside the present analysis.

geno-type

geno-type

 

Trametinib
GP2302-10MG 10 mg
EUR 418.8

Trametinib
MBS3606330-100mg 100mg
EUR 245

Trametinib
MBS3606330-10mg 10mg
EUR 200

Trametinib
MBS3606330-200mg 200mg
EUR 275

Trametinib
MBS3606330-50mg 50mg
EUR 215

Trametinib
MBS3606330-5x200mg 5x200mg
EUR 920

Trametinib
T2125-10mg 10mg Ask for price
Description: Trametinib

Trametinib
T2125-1g 1g Ask for price
Description: Trametinib

Trametinib
T2125-1mg 1mg Ask for price
Description: Trametinib

Trametinib
T2125-50mg 50mg Ask for price
Description: Trametinib

Trametinib
T2125-5mg 5mg Ask for price
Description: Trametinib

Trametinib-13C6
C988931 0.5mg
EUR 4669

Trametinib-13C6
HY-10999S1 1mg Ask for price
Description: Trametinib-13C6 is the 13C-labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2].

Ripa lysate (strong)
E1WP106 50ML
EUR 60

Trametinib-13C,d3
HY-10999S2 1mg
EUR 1007.59
Description: Trametinib-13C,d3 is the 13C- and deuterium labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2].

Trametinib-d4
HY-10999S 1mg Ask for price
Description: Trametinib-d4 is the deuterium labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2].

Trametinib-d4
T712602 100mg
EUR 4500

Deiodo Trametinib
D397050 100mg
EUR 800
Description: 871700-65-1

Trametinib (GSK1120212)
A3018-200 200 mg
EUR 153.6
Description: MAPK Signaling|MEK1/2

Trametinib (GSK1120212)
A3018-5.1 10 mM (in 1mL DMSO)
EUR 44
Description: MAPK Signaling|MEK1/2

Trametinib (GSK1120212)
A3018-50 50 mg
EUR 76.8
Description: MAPK Signaling|MEK1/2

Trametinib (GSK1120212)
A3018-500 500 mg
EUR 324
Description: MAPK Signaling|MEK1/2

Trametinib (GSK1120212)
A3018-S Evaluation Sample
EUR 24
Description: MAPK Signaling|MEK1/2

Trametinib (GSK1120212)
MBS576333-100mg 100mg
EUR 180

Trametinib (GSK1120212)
MBS576333-10mg 10mg
EUR 145

Trametinib (GSK1120212)
MBS576333-200mg 200mg
EUR 210

Trametinib (GSK1120212)
MBS576333-50mg 50mg
EUR 155

Trametinib (GSK1120212)
MBS576333-5mg 5mg
EUR 130

Trametinib DMSO solvate
A3887-10 10 mg
EUR 40
Description: MAPK Signaling|MEK1/2

Trametinib DMSO solvate
A3887-100 100 mg
EUR 95.2
Description: MAPK Signaling|MEK1/2

Trametinib DMSO solvate
A3887-5.1 10 mM (in 1mL DMSO)
EUR 44
Description: MAPK Signaling|MEK1/2

Trametinib DMSO solvate
A3887-50 50 mg
EUR 64
Description: MAPK Signaling|MEK1/2

Trametinib DMSO solvate
123211 10.0mg
EUR 90

Trametinib (DMSO solvate)
HY-10999A 100mg
EUR 75.76
Description: Trametinib (DMSO solvate) (GSK-1120212 (DMSO solvate);JTP-74057 (DMSO solvate)) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib (DMSO solvate) activates autophagy and induces apoptosis[1][2].

Trametinib DMSO solvate
MBS3600640-100mg 100mg
EUR 245

Trametinib DMSO solvate
MBS3600640-10mg 10mg
EUR 200

Trametinib DMSO solvate
MBS3600640-200mg 200mg
EUR 290

Trametinib DMSO solvate
MBS3600640-25mg 25mg
EUR 200

Trametinib DMSO solvate
MBS3600640-50mg 50mg
EUR 220

Trametinib (DMSO solvate)
MBS3845880-100mg 100mg
EUR 425

Trametinib (DMSO solvate)
MBS3845880-10mg 10mg
EUR 140

Trametinib (DMSO solvate)
MBS3845880-25mg 25mg
EUR 200

Trametinib (DMSO solvate)
MBS3845880-50mg 50mg
EUR 275

Trametinib (DMSO solvate)
MBS3845880-5x100mg 5x100mg
EUR 1910

Trametinib DMSO solvate
MBS5752199-100mg 100mg
EUR 180

Trametinib DMSO solvate
MBS5752199-10mg 10mg
EUR 145

Trametinib DMSO solvate
MBS5752199-200mg 200mg
EUR 225

Trametinib DMSO solvate
MBS5752199-25mg 25mg
EUR 145

Trametinib DMSO solvate
MBS5752199-50mg 50mg
EUR 160

Trametinib (DMSO Solvate)
T314310 100mg
EUR 800
Description: 1187431-43-1

Trametinib Impurity-I
T138340 10mg
EUR 800
Description: 1383430-03-2

Trametinib (DMSO solvate)
T5857-10mg 10mg Ask for price
Description: Trametinib (DMSO solvate)

Trametinib (DMSO solvate)
T5857-1g 1g Ask for price
Description: Trametinib (DMSO solvate)

Trametinib (DMSO solvate)
T5857-1mg 1mg Ask for price
Description: Trametinib (DMSO solvate)

Trametinib (DMSO solvate)
T5857-50mg 50mg Ask for price
Description: Trametinib (DMSO solvate)

Trametinib (DMSO solvate)
T5857-5mg 5mg Ask for price
Description: Trametinib (DMSO solvate)

RIPA Lysis Buffer (Strong)
E-BC-R327-100mL 100mL
EUR 80

RIPA Lysis Buffer (Strong)
E-BC-R327-20mL 20mL
EUR 25

RIPA Lysis Buffer (Strong)
E-BC-R327-50mL 50mL
EUR 60

RIPA Lysis Buffer (Strong)
E-BC-R327-each each Ask for price

RIPA Lysis Buffer (Strong)
abx090624-100l 100 µl
EUR 150

RIPA Lysis Buffer (Strong)
abx090624-100ml 100 ml
EUR 260.4

RIPA Lysis Buffer (Strong)
abx090624-1ml 1 ml Ask for price

RIPA Lysis Buffer (Strong)
abx090624-200l 200 µl Ask for price

RIPA Lysis Buffer (Strong)
HY-K1001 100 mL
EUR 176.4

Strong RIPA Lysis Buffer
EZPS03-1 100mL
EUR 15

RIPA Lysis Buffer (Strong)
MBS355478-100mL 100mL
EUR 210

RIPA Lysis Buffer (Strong)
MBS355478-5x100mL 5x100mL
EUR 640

Carbol Fuchsin (ZN,Strong)
S005-125ML 1 unit
EUR 3.16
Description: Carbol Fuchsin (ZN,Strong)

Carbol Fuchsin (ZN,Strong)
S005-500ML 1 unit
EUR 10.92
Description: Carbol Fuchsin (ZN,Strong)

WB Stripping Solution Strong
05677-65 500ML
EUR 142.8

OOMC00081-10MG - Trametinib
OOMC00081-10MG 10mg
EUR 59

OOMC00081-50MG - Trametinib
OOMC00081-50MG 50mg
EUR 199

Trametinib [CAS# 871700-17-3]
T-8123 10 mg
EUR 38

Trametinib dimethyl sulfoxide
414033 25.0mg
EUR 228

Clear Seal Strong Sheet (100)
MAAB-0685 each
EUR 255.61

HiDecal (Strong decalcifying solution)
R085-500ML 1 unit
EUR 21.95
Description: HiDecal (Strong decalcifying solution)

Arg-SEC Mobile Phase(Strong)
17000-51 1L
EUR 105

Pierce Seal Strong Roll - 1ROLL
PCR0636 1ROLL
EUR 1314.9

GSK1120212 (JTP-74057, Trametinib)
MBS384815-100mg 100mg
EUR 210

GSK1120212 (JTP-74057, Trametinib)
MBS384815-10mg 10mg
EUR 145

GSK1120212 (JTP-74057, Trametinib)
MBS384815-1mLinDMSO 1mL(inDMSO)
EUR 145

GSK1120212 (JTP-74057, Trametinib)
MBS384815-50mg 50mg
EUR 170

GSK1120212 (JTP-74057, Trametinib)
MBS384815-5mg 5mg
EUR 130

Pierce Seal Strong Sheets - PK100
PCR0632 PK100
EUR 140.4

Tissue/cell lysis buffer（Strong)
RM17482 10mL
EUR 53.14

replacement tip Kit strong thick
INS2090 EACH
EUR 8.33

Modified Duncan Strong (DS) Medium
M1237-500G 1 unit
EUR 80.55
Description: Modified Duncan Strong (DS) Medium

Pierce Seal Strong Roll610mX78mm - 1ROLL
PCR0628 1ROLL
EUR 1104.3

Trametinib, DMSO Solvate [CAS# 1187431-43-1]
T-8188 10 mg
EUR 38

Western Stripping buffer (Strong alkaline)
EZWB03-1-100mL 100mL
EUR 9.6

Western Stripping buffer (Strong alkaline)
EZWB03-1-500mL 500mL
EUR 28.8

Tweezers Fine Strong CF Tips - EACH
INS5058 EACH
EUR 37.6

Tweezers Flat Strong CF Tips - EACH
INS5100 EACH
EUR 43.92

PCR Foil Seal Strong Sheets - PK100
PCR0528 PK100
EUR 211.95

EP Reagent Sodium Hypochlorite Sol. Strong - 500ML
10816005 500ML
EUR 136.35

Pierce Seal Strong Sample Roll - 1ROLL
PCR0630 1ROLL
EUR 59.63

replacement tip Kit strong thick - EACH
INS2058 EACH
EUR 11.65

replacement tip Kit strong point - EACH
INS2094 EACH
EUR 11.65

Modified Duncan Strong (DS) HiVeg Medium
MV1237-500G 1 unit
EUR 80.55
Description: Modified Duncan Strong (DS) HiVeg Medium

anti PAI-1 (very strong for human)
MBS480230-1mg 1mg
EUR 790

anti PAI-1 (very strong for human)
MBS480230-5x1mg 5x1mg
EUR 3315

Strong RIPA Lysis Buffer (without inhibitors)
EZPS03-2 100mL
EUR 12.6

EP Reagent Sodium Hydroxide Sol. Strong - 1L
1081404 1L
EUR 191.7

Tweezers, Rubis Sturdy, Strong Pointed, 115mm, 4.5€
25046-1 1EA
EUR 52.92

Silver Protein for Histology, Strong (not certified)
25108-25 25g
EUR 479.52
Description: 9015-51-4

Silver Protein for Histology, Strong (not certified)
25108-5 5g
EUR 125.28
Description: 9015-51-4

Magnetic Base Support Z w/ Strong Magnet - 34.5mm
M-R-1013161 1 UNIT
EUR 46
Description: Magnetic Base Support Z w/ Strong Magnet - 34.5mm

Magnetic Base Support Z w/ Strong Magnet - 27.5mm
M-R-1015229 1 UNIT
EUR 46
Description: Magnetic Base Support Z w/ Strong Magnet - 27.5mm

Seralite SRA-400, Strong Basic Anion Exchange Resin
52228 500 Gms
EUR 5.82
Description: Part A

Seralite SRC-120, Strong Acid Cation Exchange Resin
14891 500 Gms
EUR 3.76
Description: Part A

UCW5072, Low TOC Strong Base Anion Resin, OH Form
50240-1 1000ml
EUR 213.84

UCW5072, Low TOC Strong Base Anion Resin, OH Form
50240-250 250ml
EUR 69.12

A510, Type 2 Macroporous Strong Base Rsin, Chloride Form
50223-1 1000ml
EUR 160.92
Description: 69011-15-0

DiagAg™ Strong Anion Exchange Agarose Particles, 40 μm
DAG-CL23-08 25 mL
EUR 920

A510, Type 2 Macroporous Strong Base Resin, Chloride Form
50223-250 250ml
EUR 52.92
Description: 69011-15-0

A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form
50218-1 1000ml
EUR 160.92
Description: 9052-45-3

A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form
50218-250 250ml
EUR 52.92
Description: 9052-45-3

Optically clear sealing film for qPCR, Strong Bond, for PP plates, 100/pk
MS1000-PCR2 1 each
EUR 149.35

DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 24-45 µm
DAG-YS23-27 25 mL
EUR 680

 

A prognosis-predictive nomogram of ovarian most cancers with two immune-related genes: CDC20B and PNPLA5

 

Ovarian carcinoma (OV) is probably going one of the lethal gynecological malignancies globally, and the overall 5-year survival cost of OV was 47% in 2018 primarily based on American info. To increase the survival cost of victims with OV, many researchers have sought to ascertain biomarkers that act as every prognosis-predictive markers and treatment targets.

 

However, most of these have not been acceptable for scientific software program. The present analysis geared towards establishing a predictive prognostic nomogram of OV using the genes acknowledged by combining The Most cancers Genome Atlas (TCGA) dataset for OV with the immune ranking calculated by the Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression info algorithm. Firstly, the algorithm was used to calculate the immune ranking of victims with OV inside the TCGA-OV dataset.

 

Secondly, differentially expressed genes (DEGs) between excessive and low immune ranking tissues have been acknowledged, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis was carried out to predict the options of these DEGs. Thirdly, univariate, multivariate and Lasso Cox’s regression analyses have been carried out step-by-step, and 6 prognosis-relatedDEGs have been acknowledged.

 

Then, Kaplan-Myer survival curves have been generated for these genes and validated by evaluating their expression ranges to extra slender the fluctuate of DEGs and to calculate the hazard ranking. Two genes have been acknowledged, cell division cycle 20B and patatin-like phospholipase space containing 5, which have been every confirmed to have elevated expression ranges in OV tissues and to be significantly associated to the prognosis of OV.

 

Subsequent, a nomogram was created using these two genes and age, and using the receiver working attribute (ROC) curve and calibration curve, the effectiveness of the nomogram was validated. Lastly, an exterior validation was carried out for this nomogram. The ROC confirmed that the areas beneath the curve (AUCs) of the 3- and 5-year whole survival predictions for the nomogram have been 0.678 and 0.62, respectively. Moreover, the ROC of the outside validation model confirmed that the AUCs of the 3- and 5-year have been 0.699 and 0.643, respectively, demonstrating the effectiveness of the generated nomogram. In conclusion, the present analysis has acknowledged two immune-related genes as biomarkers that reliably predict whole survival in OV. These biomarkers may additionally be potential molecular targets of immune treatment to take care of victims with OV.

Evolution of the Brassicaceae-specific MS5-Like household and neofunctionalization of the novel MALE STERILITY 5 gene important for male fertility in B. napus

 

New genes (or lineage-specific genes) can facilitate useful improvements. MALE STERILITY 5 (MS5) in Brassica napus is a fertility-related new gene, which has two wild kind alleles (BnMS5a and BnMS5c ) and two mutant alleles (BnMS5b and BnMS5d ) that might induce male sterility.
Right here, we studied the historical past and useful evolution of MS5 homologs in crops by phylogenetic evaluation and molecular genetic experiments. We recognized 727 MS5 homologs and located that they outline a Brassicaceae-specific gene household that has expanded partly through a number of tandem gene duplications and likewise in all probability transpositions. The MS5 in B. napus is inherited from a fundamental diploid ancestor of B. rapa.
Molecular genetic experiments point out that BnMS5a and BnMS5c are functionally distinct in B. napus and that BnMS5d can inhibit BnMS5a in B. napus in a dosage-dependent method.
The BnMS5a protein can transfer in coordination with meiotic telomeres and work together with the nuclear envelope protein SUN1, with a potential essential position in meiotic chromosome habits. In abstract, BnMS5 belongs to a Brassicaceae-specific new gene household, and has gained a novel operate that’s important for male fertility in B. napus via neofunctionalization that has doubtless occurred because the origin of B. rapa.

BPA’s transgenerational disturbance to transcription of ovarian steroidogenic genes in uncommon minnow Gobiocypris rarus through DNA and histone methylation

As a well known estrogenic endocrine disruptor, bisphenol A (BPA) is of utmost concern since it’s reported with dangerous results on animal copy. Nonetheless, the opposed results on progeny after parental BPA publicity are largely unknown in fishes.
To analyze the epigenetic results of BPA on progeny gonadal growth, parental uncommon minnow (Gobiocypris rarus) had been uncovered to BPA (15 μg L-1) for 2 months, then had been purged in clear water for one, two or three months, respectively. From the second month, dad and mom had been mated as soon as a month and the offspring had been reared to five months previous.
Outcomes confirmed that parental BPA publicity inhibited the ovary growth of the offspring by decreasing the variety of mature oocytes whereas the transcripts of steroidogenic genes (cyp11a1, cyp17a1, cyp19a1a and star) had been considerably affected. And the detrimental results of parental BPA publicity on the offspring had been reversible.
The DNA methylation and histone trimethylation ranges (H3K9me3 and H3K27me3) along with the expression of dnmts (dnmt1, dnmt5 and dnmt7) and histone methyltransferase genes (setdb1, setdb2 and ezh2) had been considerably altered within the ovaries of the 5-month previous offsprings.
BPA interfered the expression of steroidogenic genes by altering histone recruitment in star (H3K4me3 and H3K9me3), in cyp11a1 and cyp17a1 (H3K9me3 and H3K27me3), in addition to in cyp19a1a (H3K4me3, H3K9me3 and H3K27me3).
As well as, altering of DNA methylation at CpG website brought on by BPA publicity concerned within the regulation of star, cyp17a1 and cyp19a1a expression. These outcomes recommend that BPA transgenerationally imposes detriment to copy and the epigenetic adjustments in DNA methylation and histone trimethylation may account for steroidogenic genes expression.

Strong RIPA Lysis Buffer
EZPS03-1 100mL
EUR 15

RIPA Lysis Buffer (Strong)
MBS355478-100mL 100mL
EUR 210

RIPA Lysis Buffer (Strong)
MBS355478-5x100mL 5x100mL
EUR 640

Carbol Fuchsin (ZN,Strong)
S005-125ML 1 unit
EUR 3.16
Description: Carbol Fuchsin (ZN,Strong)

Carbol Fuchsin (ZN,Strong)
S005-500ML 1 unit
EUR 10.92
Description: Carbol Fuchsin (ZN,Strong)

WB Stripping Solution Strong
05677-65 500ML
EUR 142.8

Clear Seal Strong Sheet (100)
MAAB-0685 each
EUR 255.61

HiDecal (Strong decalcifying solution)
R085-500ML 1 unit
EUR 21.95
Description: HiDecal (Strong decalcifying solution)

Arg-SEC Mobile Phase(Strong)
17000-51 1L
EUR 105

Pierce Seal Strong Roll - 1ROLL
PCR0636 1ROLL
EUR 1314.9

Pierce Seal Strong Sheets - PK100
PCR0632 PK100
EUR 140.4

Tissue/cell lysis buffer（Strong)
RM17482 10mL
EUR 53.14

replacement tip Kit strong thick
INS2090 EACH
EUR 8.33

Modified Duncan Strong (DS) Medium
M1237-500G 1 unit
EUR 80.55
Description: Modified Duncan Strong (DS) Medium

Pierce Seal Strong Roll610mX78mm - 1ROLL
PCR0628 1ROLL
EUR 1104.3

Western Stripping buffer (Strong alkaline)
EZWB03-1-100mL 100mL
EUR 9.6

Western Stripping buffer (Strong alkaline)
EZWB03-1-500mL 500mL
EUR 28.8

Tweezers Fine Strong CF Tips - EACH
INS5058 EACH
EUR 37.6

Tweezers Flat Strong CF Tips - EACH
INS5100 EACH
EUR 43.92

PCR Foil Seal Strong Sheets - PK100
PCR0528 PK100
EUR 211.95

EP Reagent Sodium Hypochlorite Sol. Strong - 500ML
10816005 500ML
EUR 136.35

Pierce Seal Strong Sample Roll - 1ROLL
PCR0630 1ROLL
EUR 59.63

replacement tip Kit strong thick - EACH
INS2058 EACH
EUR 11.65

replacement tip Kit strong point - EACH
INS2094 EACH
EUR 11.65

Modified Duncan Strong (DS) HiVeg Medium
MV1237-500G 1 unit
EUR 80.55
Description: Modified Duncan Strong (DS) HiVeg Medium

anti PAI-1 (very strong for human)
MBS480230-1mg 1mg
EUR 790

anti PAI-1 (very strong for human)
MBS480230-5x1mg 5x1mg
EUR 3315

Strong RIPA Lysis Buffer (without inhibitors)
EZPS03-2 100mL
EUR 12.6

EP Reagent Sodium Hydroxide Sol. Strong - 1L
1081404 1L
EUR 191.7

Tweezers, Rubis Sturdy, Strong Pointed, 115mm, 4.5€
25046-1 1EA
EUR 52.92

Silver Protein for Histology, Strong (not certified)
25108-25 25g
EUR 479.52
Description: 9015-51-4

Silver Protein for Histology, Strong (not certified)
25108-5 5g
EUR 125.28
Description: 9015-51-4

Magnetic Base Support Z w/ Strong Magnet - 34.5mm
M-R-1013161 1 UNIT
EUR 46
Description: Magnetic Base Support Z w/ Strong Magnet - 34.5mm

Magnetic Base Support Z w/ Strong Magnet - 27.5mm
M-R-1015229 1 UNIT
EUR 46
Description: Magnetic Base Support Z w/ Strong Magnet - 27.5mm

Seralite SRA-400, Strong Basic Anion Exchange Resin
52228 500 Gms
EUR 5.82
Description: Part A

Seralite SRC-120, Strong Acid Cation Exchange Resin
14891 500 Gms
EUR 3.76
Description: Part A

UCW5072, Low TOC Strong Base Anion Resin, OH Form
50240-1 1000ml
EUR 213.84

UCW5072, Low TOC Strong Base Anion Resin, OH Form
50240-250 250ml
EUR 69.12

A510, Type 2 Macroporous Strong Base Rsin, Chloride Form
50223-1 1000ml
EUR 160.92
Description: 69011-15-0

DiagAg™ Strong Anion Exchange Agarose Particles, 40 μm
DAG-CL23-08 25 mL
EUR 920

A510, Type 2 Macroporous Strong Base Resin, Chloride Form
50223-250 250ml
EUR 52.92
Description: 69011-15-0

A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form
50218-1 1000ml
EUR 160.92
Description: 9052-45-3

A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form
50218-250 250ml
EUR 52.92
Description: 9052-45-3

Optically clear sealing film for qPCR, Strong Bond, for PP plates, 100/pk
MS1000-PCR2 1 each
EUR 149.35

DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 24-45 µm
DAG-YS23-27 25 mL
EUR 680

Rapamycin
41810000-1 10 mg
EUR 67.17

Rapamycin
41810000-2 100 mg
EUR 207.39

Rapamycin
41810000-3 50 mg
EUR 115.48

Rapamycin
41810000-4 500 mg
EUR 468.99

Rapamycin
30037-94 100UG
EUR 138.6

Rapamycin
22470-54 100ug
EUR 175.95
Description: 53123-88-9

Rapamycin
27062 50 mg
EUR 135
Description: Immunosuppressant, related to FK-506, but without calcineurin inhibitory activity even when complexed to FK-506 binding protein. Selectively blocks signaling that leads to p70 S6 kinase activation (IC50 = 50 pM).

Rapamycin
1568-5 each
EUR 339.6

Rapamycin
1568-50 each
EUR 1396.8

Rapamycin
20-abx185560
  • Ask for price
  • Ask for price
  • 5 mg
  • 25 mg

Rapamycin
abx076788-100l 100 µl
EUR 118.75

Rapamycin
abx076788-1ml 1 ml Ask for price

Rapamycin
abx076788-200l 200 µl
EUR 300

Rapamycin
20-abx076788
  • Ask for price
  • Ask for price
  • 5 mg
  • 25 mg

Rapamycin
MBS132175-100mg 100mg
EUR 1065

Rapamycin
MBS132175-500mg 500mg
EUR 2775

Rapamycin
HY-10219 200mg
EUR 272.73
Description: Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[1]. Rapamycin is an autophagy activator, an immunosuppressant[2].

Rapamycin
GA7417 5mg
EUR 181.03

Rapamycin
GA7417-100 100
EUR 197.7

Rapamycin
GA7417-100MG 100 mg
EUR 274.8

Rapamycin
GA7417-25 25
EUR 63.3

Rapamycin
GA7417-25MG 25 mg
EUR 112.8

Rapamycin
GA7417-5 5
EUR 23.8

Rapamycin
GA7417-50 50
EUR 118.7

Rapamycin
GA7417-50MG 50 mg
EUR 180

Rapamycin
GA7417-5MG 5 mg
EUR 64.8

Rapamycin
G613 100 mg
EUR 800

Rapamycin
E1B1842 1mg
EUR 60

Rapamycin
MBS3604884-100mg 100mg
EUR 210

Rapamycin
MBS3604884-200mg 200mg
EUR 240

Rapamycin
MBS3604884-50mg 50mg
EUR 195

Rapamycin
MBS3604884-5x200mg 5x200mg
EUR 760

Rapamycin
MBS515013-100mg 100mg
EUR 665

Rapamycin
MBS515013-20mg 20mg
EUR 320

Rapamycin
MBS515013-5x100mg 5x100mg
EUR 2740

Rapamycin
MBS696245-10mg 10mg
EUR 235

Rapamycin
MBS696245-1mg 1mg
EUR 135

Rapamycin
MBS696245-5x10mg 5x10mg
EUR 1005

Rapamycin
MBS807957-25mg 25mg
EUR 450

Rapamycin
MBS807957-5mg 5mg
EUR 260

Rapamycin
MBS807957-5x25mg 5x25mg
EUR 1770

Rapamycin
MBS807957-5x5mg 5x5mg
EUR 905

Rapamycin
MBS8579821-1mg 1mg
EUR 155

Rapamycin
MBS8579821-5x1mg 5x1mg
EUR 555

Rapamycin
tlrl-rap-5 5 x 5 mg
EUR 248.85

Rapamycin
MBS407517-100mg 100mg
EUR 175

Rapamycin
MBS407517-1g 1g
EUR 450

Rapamycin
MBS407517-5x100mg 5x100mg
EUR 730

Rapamycin
MBS407517-5x1g 5x1g
EUR 1970

Rapamycin
T1537-10mg 10mg Ask for price
Description: Rapamycin

Rapamycin
T1537-1g 1g Ask for price
Description: Rapamycin

Rapamycin
T1537-1mg 1mg Ask for price
Description: Rapamycin

Rapamycin
T1537-50mg 50mg Ask for price
Description: Rapamycin

Rapamycin
T1537-5mg 5mg Ask for price
Description: Rapamycin

Rapamycin
SIH-212-25MG 25 mg
EUR 276

Rapamycin
SIH-212-5MG 5 mg
EUR 110.4

Rapamycin
R001-10MG 10 mg
EUR 152.4
Description: 53123-88-9

Rapamycin
R001-25MG 25 mg
EUR 191.52
Description: 53123-88-9

Rapamycin, 100mg
R5312 100mg
EUR 607.18

Rapamycin, 100mg
R5312-100mg each
EUR 902.4

Rapamycin, >99%
BC082-050 50mg
EUR 142

Rapamycin, >99%
BC082-100 100mg
EUR 176

Rapamycin, >99%
BC082-250 250mg
EUR 250

Rapamycin, >99%
BC082-500 500mg
EUR 385

Rapamycin (>85%)
R124000 100mg
EUR 80
Description: 53123-88-9

Rapamycin (GMP)
HY-10219G Get quote Ask for price
Description: Rapamycin (Sirolimus) (GMP) is Rapamycin (HY-10219) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Rapamycin is a potent and specific mTOR inhibitor[1][2][3].

Rapamycin-13C, D3
ESS0567-5mg 5 mg
EUR 840
Description: Sirolimus-13C, D3

Rapamycin-13C,d3
HY-10219S1 Get quote Ask for price
Description: Rapamycin-13C,d3 (Sirolimus-13C,d3; AY-22989-13C,d3) is the 13C and deuterium labeled Rapamycin (HY-10219)[1]. Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[2]. Rapamycin is an autophagy activator, an immunosuppressant[3].

Seco Rapamycin
HY-19555 50mg
EUR 2704.8
Description: Seco Rapamycin (Secorapamycin A) is the ring-opened product of Rapamycin. Seco-rapamycin is reported not to affect the mTOR function[1].

Rapamycin-D3
ESS0404-5mg 5 mg
EUR 630
Description: Sirolimus-D3

Rapamycin-d3
HY-10219S 1 mg
EUR 119.05
Description: Rapamycin-d3 is the deuterium labeled Rapamycin. Rapamycin is a potent and specific mTOR inhibitor with an IC50of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[1]. Rapamycin is an autophagy activator, an immunosuppressant[2].

Seco Rapamycin
MBS5799522-5mg 5(mg
EUR 915

Seco Rapamycin
MBS5799522-5x5mg 5x5(mg
EUR 3970

Rapamycin-d3
T12691-10mg 10mg Ask for price
Description: Rapamycin-d3

Rapamycin-d3
T12691-1g 1g Ask for price
Description: Rapamycin-d3

Rapamycin-d3
T12691-1mg 1mg Ask for price
Description: Rapamycin-d3

Rapamycin-d3
T12691-50mg 50mg Ask for price
Description: Rapamycin-d3

Rapamycin-d3
T12691-5mg 5mg Ask for price
Description: Rapamycin-d3

Rapamycin, 10mg
R5312-10mg each
EUR 244.8

Seco Rapamycin
T38963-10mg 10mg Ask for price
Description: Seco Rapamycin

Seco Rapamycin
T38963-1g 1g Ask for price
Description: Seco Rapamycin

Seco Rapamycin
T38963-1mg 1mg Ask for price
Description: Seco Rapamycin

Seco Rapamycin
T38963-50mg 50mg Ask for price
Description: Seco Rapamycin

Seco Rapamycin
T38963-5mg 5mg Ask for price
Description: Seco Rapamycin

DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, Low Capacity
DAG-YS23-28 25 mL
EUR 680

DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, High Capacity
DAG-YS23-29 25 mL
EUR 680

Sirolimus (Rapamycin)
100766 25.0mg
EUR 90

Rapamycin (Sirolimus)
A8167-100 100 mg
EUR 154.4
Description: PI3K/Akt/mTOR Signaling|mTOR

Rapamycin (Sirolimus)
A8167-25 25 mg
EUR 81.6
Description: PI3K/Akt/mTOR Signaling|mTOR

Rapamycin (Sirolimus)
A8167-5 5 mg
EUR 40
Description: PI3K/Akt/mTOR Signaling|mTOR

Rapamycin (Sirolimus)
A8167-5.1 10 mM (in 1mL DMSO)
EUR 48
Description: PI3K/Akt/mTOR Signaling|mTOR

Rapamycin (Sirolimus)
A8167-S Evaluation Sample
EUR 24
Description: PI3K/Akt/mTOR Signaling|mTOR

Rapamycin (Sirolimus)
E1KS1039 50mg
EUR 120

Rapamycin (Sirolimus)
MBS386035-100mg 100mg
EUR 160

Rapamycin (Sirolimus)
MBS386035-1mLinDMSO 1mL(inDMSO)
EUR 140

Rapamycin (Sirolimus)
MBS386035-50mg 50mg
EUR 145

Rapamycin (Sirolimus)
MBS386035-5mg 5mg
EUR 130

Rapamycin (Sirolimus)
MBS386035-5x100mg 5x100mg
EUR 715

Rapamycin (Sirolimus)
MBS575148-100mg 100mg
EUR 155

Rapamycin (Sirolimus)
MBS575148-200mg 200mg
EUR 185

Rapamycin (Sirolimus)
MBS575148-25mg 25mg
EUR 135

Rapamycin (Sirolimus)
MBS575148-500mg 500mg
EUR 260

Rapamycin (Sirolimus)
MBS575148-50mg 50mg
EUR 145

Rapamycin (Sirolimus)
MBS8506576-50mg 50mg
EUR 210

Rapamycin (Sirolimus)
MBS8506576-5x50mg 5x50mg
EUR 800

Foil seals, strong bonding for cold storage (-200 to 110°C) and DMSO, for PP plates, 100/pk
MS1000-F2 1 each
EUR 149.35

EZSolution? Rapamycin
1746-5 each
EUR 326.4

Rapamycin analog-2
HY-153511 Get quote Ask for price
Description: Rapamycin analog-2 (compound A) is a Rapamycin analog[1].

Estrogen receptor (ER) IHC control with strong, moderate, low/negative expressersHumanBreastBreastIHC control
ERC083 1.5mm
EUR 50

rapamycin derivative 1
R454500 25mg
EUR 1800

rapamycin derivative 2
R574880 100mg
EUR 9200

TOR | Target of rapamycin
AS12-2608 50 µg
EUR 302

OOMC00007-10MG - Rapamycin
OOMC00007-10MG 10mg
EUR 69

OOMC00007-50MG - Rapamycin
OOMC00007-50MG 50mg
EUR 249

Rapamycin-31,42-Diester Impurity
R124015 50mg
EUR 1938

Rapamycin [CAS# 53123-88-9]
R-5000 50 mg
EUR 48

42-O-Formyl Rapamycin
ESS0554-5mg 5 mg
EUR 525
Description: Everolimus EP Impurity E

33-O-Formyl Rapamycin
F699010 10mg
EUR 1728

Seco Rapamycin (sodium salt)
HY-19555A 1mg
EUR 2077.95
Description: Seco Rapamycin sodium salt is the ring-opened product of Rapamycin. Seco-rapamycin is reported not to affect the mTOR function.

Seco Rapamycin ethyl ester
HY-133770 10 mg
EUR 2380.99
Description: Seco Rapamycin ethyl ester is an open-ring metabolite of Rapamycin derivative. Seco-rapamycin is reported not to affect the mTOR function[1].

7-O-Demethyl rapamycin
HY-123691 Get quote Ask for price
Description: 7-O-Demethyl rapamycin, a derivative of Rapamycin (HY-10219), has antifungal activity and immunosuppressant properties. 7-O-Demethyl rapamycin has useful tumor cell growth-inhibiting activity[1].

Seco Rapamycin sodium salt
MBS3602049-10mg 10mg
EUR 655

Seco Rapamycin sodium salt
MBS3602049-25mg 25mg
EUR 1075

Seco Rapamycin sodium salt
MBS3602049-50mg 50mg
EUR 1630

Seco Rapamycin sodium salt
MBS3602049-5mg 5mg
EUR 465

Seco Rapamycin sodium salt
MBS3602049-5x50mg 5x50mg
EUR 7015

Seco Rapamycin sodium salt
MBS5756112-25mg 25mg
EUR 1405

Seco Rapamycin sodium salt
MBS5756112-50mg 50mg
EUR 2410

Seco Rapamycin sodium salt
MBS5756112-5x50mg 5x50mg
EUR 10695

7-O-Demethyl Rapamycin
MBS6080732-25mg 2.5(mg
EUR 665

7-O-Demethyl Rapamycin
MBS6080732-5x25mg 5x2.5mg
EUR 2845

7-O-Demethyl rapamycin
MBS5775613-10mg 10mg
EUR 2020

7-O-Demethyl rapamycin
MBS5775613-25mg 25mg
EUR 1995

7-O-Demethyl rapamycin
MBS5775613-5mg 5(mg
EUR 1235

Seco Rapamycin sodium salt
T19558-10mg 10mg Ask for price
Description: Seco Rapamycin sodium salt

Seco Rapamycin sodium salt
T19558-1g 1g Ask for price
Description: Seco Rapamycin sodium salt

Seco Rapamycin sodium salt
T19558-1mg 1mg Ask for price
Description: Seco Rapamycin sodium salt

Seco Rapamycin sodium salt
T19558-50mg 50mg Ask for price
Description: Seco Rapamycin sodium salt

Seco Rapamycin sodium salt
T19558-5mg 5mg Ask for price
Description: Seco Rapamycin sodium salt

7-O-Demethyl rapamycin
T25882-10mg 10mg Ask for price
Description: 7-O-Demethyl rapamycin

7-O-Demethyl rapamycin
T25882-1g 1g Ask for price
Description: 7-O-Demethyl rapamycin

7-O-Demethyl rapamycin
T25882-1mg 1mg Ask for price
Description: 7-O-Demethyl rapamycin

7-O-Demethyl rapamycin
T25882-50mg 50mg Ask for price
Description: 7-O-Demethyl rapamycin

7-O-Demethyl rapamycin
T25882-5mg 5mg Ask for price
Description: 7-O-Demethyl rapamycin

42-(2-Tetrazolyl)rapamycin
HY-12424A 1mg
EUR 311.69
Description: 42-(2-Tetrazolyl)rapamycin is a proagent compound of a rapamycin analog extracted from patent US 20080171763 A1, Example 1. Rapamycin is a specific mTOR inhibitor.
Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,